We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
C3.ai Expands Generative AI Capabilities: Game Changer or Hype?
Read MoreHide Full Article
Key Takeaways
AI reported more than 100% y/y revenue growth in Generative AI with 66 deployments across 16 industries.
AI holds a patent on agentic AI with 100+ solutions deployed, targeting defense, government and manufacturing.
AI stock up 41.2% in 3 months and trades at a discount, with narrowing projected losses through fiscal 2027.
C3.ai, Inc. (AI - Free Report) is doubling down on Generative and agentic AI, and the market is watching closely.
In fiscal 2025, C3.ai showcased major momentum in its Generative and agentic-AI efforts. The company reported more than 100% year-over-year growth in Generative-AI revenues, with 66 initial production deployments across 16 industries in a year. Clients include the U.S. Navy, Dow, Chanel and the Shoah Foundation, which is using C3’s platform to digitize and tag 30,000 survivor testimonies, saving a decade of manual effort and millions in costs.
Equally notable is C3.ai’s claim of holding a patent on agentic AI, with more than 100 solutions already deployed. These applications span defense, manufacturing and government. Management believes this vertical alone could be worth more than the company’s current valuation.
Still, questions remain. Despite the impressive demos and high-profile deployments, many of these deals are early-stage production licenses, not recurring revenues. Investors should also be cautious about lofty projections amid broader market and geopolitical uncertainties.
What makes C3.ai’s pitch different is its pure-play focus on enterprise-AI applications rather than infrastructure or toolkits. That may give the company a lasting advantage if it can scale fast enough through expanding partnerships with Microsoft, AWS and Google Cloud.
While hype surrounds anything "Generative AI," C3.ai appears to be walking the talk. Whether it becomes a long-term leader will depend on sustained customer adoption, ecosystem execution and the elusive path to profitability.
How Does C3.ai Stack Up Against Palantir & Snowflake?
While C3.ai is leaning hard into turnkey Generative and agentic AI solutions, competitors like Palantir Technologies Inc. (PLTR - Free Report) and Snowflake Inc. (SNOW - Free Report) are charting their aggressive paths in the enterprise AI race.
Palantir, long entrenched in government and defense sectors, is rapidly expanding its Artificial Intelligence Platform to commercial clients. Unlike C3.ai’s pre-built applications, Palantir emphasizes custom deployments and integration flexibility, especially for data-rich industries like manufacturing and energy. Its stronghold in defense mirrors C3.ai’s PANDA deployment with the U.S. Air Force, suggesting intensifying competition in federal AI contracts.
Snowflake, meanwhile, is evolving from a cloud data platform into an AI-enabled ecosystem. With the launch of Cortex, its Generative AI service, Snowflake is helping clients build custom LLM-powered apps directly within their data environments. This integration-first approach contrasts with C3.ai’s application-first model but appeals to enterprises seeking tighter control over data pipelines.
AI’s Price Performance, Valuation & Estimates
AI shares have gained 41.2% in the past three months compared with the industry’s growth of 23.1%.
Price Performance
Image Source: Zacks Investment Research
Despite the recent gain, AI is priced at a discount relative to its industry. It has a forward 12-month price-to-sales ratio of 7.12, which is well below the industry average.
P/S (F12M)
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for fiscal 2026 loss per share has narrowed to 37 cents from a loss of 46 cents in the past 30 days. Moreover, the consensus mark for fiscal 2027 loss per share has narrowed to 16 cents from a loss of 42 cents in the same time frame.
Image: Bigstock
C3.ai Expands Generative AI Capabilities: Game Changer or Hype?
Key Takeaways
C3.ai, Inc. (AI - Free Report) is doubling down on Generative and agentic AI, and the market is watching closely.
In fiscal 2025, C3.ai showcased major momentum in its Generative and agentic-AI efforts. The company reported more than 100% year-over-year growth in Generative-AI revenues, with 66 initial production deployments across 16 industries in a year. Clients include the U.S. Navy, Dow, Chanel and the Shoah Foundation, which is using C3’s platform to digitize and tag 30,000 survivor testimonies, saving a decade of manual effort and millions in costs.
Equally notable is C3.ai’s claim of holding a patent on agentic AI, with more than 100 solutions already deployed. These applications span defense, manufacturing and government. Management believes this vertical alone could be worth more than the company’s current valuation.
Still, questions remain. Despite the impressive demos and high-profile deployments, many of these deals are early-stage production licenses, not recurring revenues. Investors should also be cautious about lofty projections amid broader market and geopolitical uncertainties.
What makes C3.ai’s pitch different is its pure-play focus on enterprise-AI applications rather than infrastructure or toolkits. That may give the company a lasting advantage if it can scale fast enough through expanding partnerships with Microsoft, AWS and Google Cloud.
While hype surrounds anything "Generative AI," C3.ai appears to be walking the talk. Whether it becomes a long-term leader will depend on sustained customer adoption, ecosystem execution and the elusive path to profitability.
How Does C3.ai Stack Up Against Palantir & Snowflake?
While C3.ai is leaning hard into turnkey Generative and agentic AI solutions, competitors like Palantir Technologies Inc. (PLTR - Free Report) and Snowflake Inc. (SNOW - Free Report) are charting their aggressive paths in the enterprise AI race.
Palantir, long entrenched in government and defense sectors, is rapidly expanding its Artificial Intelligence Platform to commercial clients. Unlike C3.ai’s pre-built applications, Palantir emphasizes custom deployments and integration flexibility, especially for data-rich industries like manufacturing and energy. Its stronghold in defense mirrors C3.ai’s PANDA deployment with the U.S. Air Force, suggesting intensifying competition in federal AI contracts.
Snowflake, meanwhile, is evolving from a cloud data platform into an AI-enabled ecosystem. With the launch of Cortex, its Generative AI service, Snowflake is helping clients build custom LLM-powered apps directly within their data environments. This integration-first approach contrasts with C3.ai’s application-first model but appeals to enterprises seeking tighter control over data pipelines.
AI’s Price Performance, Valuation & Estimates
AI shares have gained 41.2% in the past three months compared with the industry’s growth of 23.1%.
Price Performance
Image Source: Zacks Investment Research
Despite the recent gain, AI is priced at a discount relative to its industry. It has a forward 12-month price-to-sales ratio of 7.12, which is well below the industry average.
P/S (F12M)
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for fiscal 2026 loss per share has narrowed to 37 cents from a loss of 46 cents in the past 30 days. Moreover, the consensus mark for fiscal 2027 loss per share has narrowed to 16 cents from a loss of 42 cents in the same time frame.
Image Source: Zacks Investment Research
The company currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.